BRNS vs FITB · $38.2M cap vs P/E 17, rev $3.37B
Barinthus Biotherapeutics plc (BRNS) versus Fifth Third Bancorp (FITB) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
BRNS currently screens at market cap $38.2M. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Not investment advice. Open the BRNS and FITB stock pages for the full models.
Not investment advice.